These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
96 related items for PubMed ID: 15056491
1. High-glucose-induced structural changes in the heparan sulfate proteoglycan, perlecan, of cultured human aortic endothelial cells. Vogl-Willis CA, Edwards IJ. Biochim Biophys Acta; 2004 Apr 07; 1672(1):36-45. PubMed ID: 15056491 [Abstract] [Full Text] [Related]
2. Distinct effects of glucose and glucosamine on vascular endothelial and smooth muscle cells: evidence for a protective role for glucosamine in atherosclerosis. Duan W, Paka L, Pillarisetti S. Cardiovasc Diabetol; 2005 Oct 05; 4():16. PubMed ID: 16207378 [Abstract] [Full Text] [Related]
3. High glucose-induced alterations in subendothelial matrix perlecan leads to increased monocyte binding. Vogl-Willis CA, Edwards IJ. Arterioscler Thromb Vasc Biol; 2004 May 05; 24(5):858-63. PubMed ID: 15031130 [Abstract] [Full Text] [Related]
4. Induction of synthesis of a large heparan sulfate proteoglycan, perlecan, by thrombin in cultured human coronary smooth muscle cells. Yamamoto C, Wakata T, Fujiwara Y, Kaji T. Biochim Biophys Acta; 2005 Feb 11; 1722(1):92-102. PubMed ID: 15716125 [Abstract] [Full Text] [Related]
5. Alteration of endothelial proteoglycan and heparanase gene expression by high glucose, insulin and heparin. Han J, Hiebert LM. Vascul Pharmacol; 2013 Feb 11; 59(3-4):112-8. PubMed ID: 23939434 [Abstract] [Full Text] [Related]
6. Heparan and chondroitin sulfate on growth plate perlecan mediate binding and delivery of FGF-2 to FGF receptors. Smith SM, West LA, Govindraj P, Zhang X, Ornitz DM, Hassell JR. Matrix Biol; 2007 Apr 11; 26(3):175-84. PubMed ID: 17169545 [Abstract] [Full Text] [Related]
7. Perlecan is responsible for thrombospondin 1 binding on the cell surface of cultured porcine endothelial cells. Vischer P, Feitsma K, Schön P, Völker W. Eur J Cell Biol; 1997 Aug 11; 73(4):332-43. PubMed ID: 9270876 [Abstract] [Full Text] [Related]
8. Anionic biopolyelectrolytes of the syndecan/perlecan superfamily: physicochemical properties and medical significance. Siegel G, Malmsten M, Ermilov E. Adv Colloid Interface Sci; 2014 Mar 11; 205():275-318. PubMed ID: 24534475 [Abstract] [Full Text] [Related]
10. Matrix glycosaminoglycans in the growth phase of fibroblasts: more of the story in wound healing. Kosir MA, Quinn CC, Wang W, Tromp G. J Surg Res; 2000 Jul 01; 92(1):45-52. PubMed ID: 10864481 [Abstract] [Full Text] [Related]
11. Regulation of glomerular endothelial cell proteoglycans by glucose. Ha TS, Duraisamy S, Faulkner JL, Kasinath BS. J Korean Med Sci; 2004 Apr 01; 19(2):245-52. PubMed ID: 15082898 [Abstract] [Full Text] [Related]
12. Heparan sulfate expression is affected by inflammatory stimuli in primary human endothelial cells. Reine TM, Kusche-Gullberg M, Feta A, Jenssen T, Kolset SO. Glycoconj J; 2012 Jan 01; 29(1):67-76. PubMed ID: 22187328 [Abstract] [Full Text] [Related]
13. Changes in perlecan during chondrocyte differentiation in the fetal bovine rib growth plate. West L, Govindraj P, Koob TJ, Hassell JR. J Orthop Res; 2006 Jun 01; 24(6):1317-26. PubMed ID: 16705694 [Abstract] [Full Text] [Related]
14. Chondrogenic activity of the heparan sulfate proteoglycan perlecan maps to the N-terminal domain I. French MM, Gomes RR, Timpl R, Höök M, Czymmek K, Farach-Carson MC, Carson DD. J Bone Miner Res; 2002 Jan 01; 17(1):48-55. PubMed ID: 11771669 [Abstract] [Full Text] [Related]
15. Characterization of proteoglycans synthesized by murine embryonal carcinoma cells (P19) reveals increased expression of perlecan (heparan sulfate proteoglycan) during neuronal differentiation. Sekiguchi RT, Potter-Perigo S, Braun K, Miller J, Ngo C, Fukuchi K, Wight TN, Kimata K, Snow AD. J Neurosci Res; 1994 Aug 15; 38(6):670-86. PubMed ID: 7807583 [Abstract] [Full Text] [Related]
16. Lipoprotein modulation of subendothelial heparan sulfate proteoglycans (perlecan) and atherogenicity. Pillarisetti S. Trends Cardiovasc Med; 2000 Feb 15; 10(2):60-5. PubMed ID: 11150731 [Abstract] [Full Text] [Related]
17. High glucose alters proteoglycan expression and the glycosaminoglycan composition in placentas of women with gestational diabetes mellitus and in cultured trophoblasts. Chen CP, Chang SC, Vivian Yang WC. Placenta; 2007 Feb 15; 28(2-3):97-106. PubMed ID: 16630654 [Abstract] [Full Text] [Related]
18. Ablation of Perlecan Domain 1 Heparan Sulfate Reduces Progressive Cartilage Degradation, Synovitis, and Osteophyte Size in a Preclinical Model of Posttraumatic Osteoarthritis. Shu CC, Jackson MT, Smith MM, Smith SM, Penm S, Lord MS, Whitelock JM, Little CB, Melrose J. Arthritis Rheumatol; 2016 Apr 15; 68(4):868-79. PubMed ID: 26636652 [Abstract] [Full Text] [Related]
19. Perlecan inhibits smooth muscle cell adhesion to fibronectin: role of heparan sulfate. Lundmark K, Tran PK, Kinsella MG, Clowes AW, Wight TN, Hedin U. J Cell Physiol; 2001 Jul 15; 188(1):67-74. PubMed ID: 11382923 [Abstract] [Full Text] [Related]
20. Cadmium induces the production of high molecular weight heparan sulfate proteoglycan molecules in cultured vascular endothelial cells. Ohkawara S, Yamamoto C, Fujiwara Y, Sakamoto M, Kaji T. Environ Toxicol Pharmacol; 1997 Jul 15; 3(3):187-94. PubMed ID: 21781777 [Abstract] [Full Text] [Related] Page: [Next] [New Search]